Back to top
more

Quest Diagnostics (DGX)

(Delayed Data from NYSE)

$173.00 USD

173.00
994,277

-0.27 (-0.16%)

Updated Aug 6, 2025 04:00 PM ET

After-Market: $172.98 -0.02 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (67 out of 246)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Quest Diagnostics Prioritizes Patients With Risk of Coronavirus

by Zacks Equity Research

The initiative will make Quest Diagnostics (DGX) one of the active players that are combating the public health crisis.

Zacks Equity Research

Intel, Royal Caribbean Cruises, Roche, Thermo Fisher and Quest Diagnostics highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Intel, Royal Caribbean Cruises, Roche, Thermo Fisher and Quest Diagnostics highlighted as Zacks Bull and Bear of the Day

Zacks Equity Research

QIAGEN Gets CE Nod for QIAstat-Dx Respiratory SARS-CoV-2 Test

by Zacks Equity Research

The regulatory clearance of this test has made QIAGEN (QGEN) a key player in coronavirus diagnosis.

Sriparna Ghosal headshot

Coronavirus Testing Players Gain Momentum: 3 Stocks in Focus

by Sriparna Ghosal

There are several key diagnostic testing laboratory and biotech players whose prospects seem bright on account of rigorous work on developing diagnostic testing for the coronavirus.

Zacks Equity Research

Quest Diagnostic Grows on New Acquisitions Amid Low Volume

by Zacks Equity Research

Quest Diagnostics' (DGX) latest strategic acquisitions act as major growth catalysts.

Zacks Equity Research

Thermo Fisher (TMO) Gets EUA From FDA for COVID-19 Testing

by Zacks Equity Research

The emergency authorization of this test has made Thermo Fisher (TMO) a key player in the field of coronavirus diagnosis.

Zacks Equity Research

Quest Diagnostics (DGX) to Launch Coronavirus Test Service

by Zacks Equity Research

Quest Diagnostics (DGX) aims to mobilize effective public health response to the coronavirus outbreak through quality laboratory testing.

Zacks Equity Research

LabCorp (LH) Launches Test to Detect Presence of Coronavirus

by Zacks Equity Research

LabCorp (LH), with an aim to contain the outbreak of coronavirus, launches the LabCorp 2019 Novel Coronavirus (COVID-19), NAA test.

Zacks Equity Research

Why Is Quest Diagnostics (DGX) Down 5.3% Since Last Earnings Report?

by Zacks Equity Research

Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Quest Diagnostics (DGX) Q4 Earnings Beat, Margins Strong

by Zacks Equity Research

We are upbeat about Quest Diagnostics' (DGX) expanded network access, which assists the company to expedite volume growth in Q4.

Zacks Equity Research

Quest Diagnostics (DGX) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

Quest Diagnostics (DGX) delivered earnings and revenue surprises of 4.37% and 0.41%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Quest Diagnostics (DGX) Hits a 52-Week High: What's Driving the Stock?

by Zacks Equity Research

Quest Diagnostics (DGX) gains from several positive developments like partnerships and acquisitions.

Zacks Equity Research

Quest Diagnostics to Buy Select Assets of Memorial Hermann

by Zacks Equity Research

The acquisition is a step forward in Quest Diagnostics' (DGX) commitment toward offering high-quality, cost-efficient diagnostic services in Texas,especially the Houston metropolitan area.

Urmimala Biswas headshot

New Alliances Aid Quest Diagnostics Despite Reimbursement Woes

by Urmimala Biswas

Quest Diagnostics (DGX) is currently concentrating on diagnostic information services arm and disciplined capital deployment.

Zacks Equity Research

Quest Diagnostics (DGX) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Will New Buyouts Aid Quest Diagnostics (DGX) Q4 Earnings?

by Zacks Equity Research

Quest Diagnostics' (DGX) acquisition of Clinical Laboratory Services of Boston Clinical Laboratories is expected to have been accretive to its Q4 earnings.

Zacks Equity Research

DGX or ADUS: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

DGX vs. ADUS: Which Stock Is the Better Value Option?

Sreyoshi Mukherjee headshot

Bright Near-Term Outlook for Medical Info Systems Industry

by Sreyoshi Mukherjee

As the healthcare industry experiences rapid and unprecedented technological changes, let's take a look at a few promising medical info systems stocks.

Trina Mukherjee headshot

Rosy Outlook for Outpatient and Home Healthcare Industry

by Trina Mukherjee

Growth prospects look bright for the Zacks Outpatient and Home Healthcare industry, thanks to AI, cost effectiveness and participation in APM.

Zacks Equity Research

Here's Why You Should Hold on to Quest Diagnostics Stock Now

by Zacks Equity Research

Investors can retain Quest Diagnostics (DGX) stock in their portfolio, thanks to solid prospects.

Zacks Equity Research

Quest Diagnostics (DGX) Up 1.9% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Quest Diagnostics (DGX) Q3 Earnings Surpass, View Strong

by Zacks Equity Research

We are upbeat about Quest Diagnostics' (DGX) expanded network access, which assists the company to accelerate volume growth in Q3.

Zacks Equity Research

Will New Alliances Aid Quest Diagnostics (DGX) Q3 Earnings?

by Zacks Equity Research

Quest Diagnostics (DGX) is likely to have retained its two-pronged agenda to accelerate growth and drive operational excellence in the third quarter.

Zacks Equity Research

LabCorp (LH) Names Two Leaders for Major Business Wings

by Zacks Equity Research

Managenment believes that under Schechter's term with Paul and John's crucial support, LabCorp (LH) looks well-positioned to grow and thrive in times ahead.

Zacks Equity Research

LabCorp to Expand Hematology Suite With Sysmex America Deal

by Zacks Equity Research

LabCorp (LH) will get to use Sysmex' advanced XN-9100 system, which is a scalable, modular automation system.